DIMEVAR Trademark

Trademark Overview

On Sunday, January 24, 2021, a trademark application was filed for DIMEVAR with the United States Patent and Trademark Office. The USPTO has given the DIMEVAR trademark a serial number of 90484742. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, May 9, 2022. This trademark is owned by Luckwel Pharmaceuticals Inc. The DIMEVAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of diabetes, namely, glipizide; Pharmaceutical preparations and substances for the treatment of diabetes in tablet form, including orally disintegrating tablets
dimevar

General Information

Serial Number90484742
Word MarkDIMEVAR
Filing DateSunday, January 24, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, May 9, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of diabetes, namely, glipizide; Pharmaceutical preparations and substances for the treatment of diabetes in tablet form, including orally disintegrating tablets

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLuckwel Pharmaceuticals Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameLuckwel Pharmaceuticals Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 1 GRANTED
Monday, May 9, 2022SOU EXTENSION 1 FILED
Monday, May 9, 2022TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 12, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 12, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 12, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 10, 2021ASSIGNED TO EXAMINER
Tuesday, June 29, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, June 29, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, June 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, May 16, 2021WITHDRAWAL OF ATTORNEY GRANTED
Sunday, May 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Sunday, April 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, January 27, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

dimevar pharmaceutical treatment diabetes preparations substances orally disintegrating tablets including glipizide